B
ZBH icon

Barings’s Zimmer Biomet ZBH Stock Holding History

Barings’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,356
Closed -$581K – 691
2019
Q3 		$581K Hold
4,356
– – 0.01% 466
2019
Q2 		$498K Buy
4,356
+1,051
+32% +$123K 0.01% 508
2019
Q1 		$410K Hold
3,305
– – 0.01% 578
2018
Q4 		$333K Hold
3,305
– – 0.01% 579
2018
Q3 		$422K Sell
3,305
-2,606
-44% -$310K 0.01% 657
2018
Q2 		$640K Buy
5,911
+1,905
+48% +$207K 0.01% 593
2018
Q1 		$424K Hold
4,006
– – 0.01% 741
2017
Q4 		$469K Hold
4,006
– – 0.01% 729
2017
Q3 		$455K Hold
4,006
– – 0.01% 672
2017
Q2 		$499K Sell
4,006
-19,929
-83% -$2.36M 0.01% 622
2017
Q1 		$2.84M Buy
23,935
+10,937
+84% +$1.24M 0.03% 498
2016
Q4 		$1.3M Buy
12,998
+8,941
+220% +$958K 0.03% 386
2016
Q3 		$512K Buy
4,057
+1,030
+34% +$127K 0.01% 563
2016
Q2 		$354K Sell
3,027
-5,480
-64% -$620K 0.01% 738
2016
Q1 		$881K Hold
8,507
– – 0.02% 527
2015
Q4 		$847K Hold
8,507
– – 0.02% 525
2015
Q3 		$776K Sell
8,507
-8,621
-50% -$864K 0.02% 524
2015
Q2 		$1.82M Hold
17,128
– – 0.05% 340
2015
Q1 		$1.95M Buy
17,128
+4,079
+31% +$465K 0.04% 329
2014
Q4 		$1.44M Hold
13,049
– – 0.03% 381
2014
Q3 		$1.27M Hold
13,049
– – 0.03% 406
2014
Q2 		$1.32M Buy
13,049
+3,327
+34% +$325K 0.04% 430
2014
Q1 		$893K Hold
9,722
– – 0.03% 492
2013
Q4 		$880K Sell
9,722
-4,326
-31% -$374K 0.04% 458
2013
Q3 		$1.12M Sell
14,048
-5,150
-27% -$405K 0.05% 394
2013
Q2 		$1.4M Buy
+19,198
New +$1.44M 0.06% 331

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Barings's ZBH Position: Q4 2019 in Review

Barings sold out of Zimmer Biomet (ZBH) in Q4 2019, closing a stake of 4,356 shares — an estimated $581K sold.

Barings first reported a position in ZBH in Q2 2013 and held it in 26 quarters. The position peaked at $2.84M in Q1 2017. 989 funds tracked by Wall St. Rank hold ZBH as of Q4 2019.

  • Barings reported no remaining Zimmer Biomet position as of Q4 2019 after selling out during the quarter.
  • Barings sold 4,356 Zimmer Biomet shares in Q4 2019, an estimated $581K.
  • Barings first reported a position in Zimmer Biomet in Q2 2013 and held it in 26 quarters.
  • Barings's Zimmer Biomet position peaked at $2.84M in Q1 2017.
  • 989 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2019.

Based on Barings's 13F filing for Q4 2019, filed 14 Feb 2020.